Latest News

FDA advisors recommend lofexidine for opioid withdrawal


 

REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING


The Prescription Drug User Fee Act (PDUFA) for lofexidine is May 26; FDA actions on new drug applications often occur at near the PDUFA date.


The FDA is not obligated to follow the recommendations of its advisory committees.

Next Article: